Logo image of ABNX.PA

ABIONYX PHARMA SA (ABNX.PA) Stock Analyst Ratings

Europe - EPA:ABNX - FR0012616852 - Common Stock

4.125 EUR
+0.09 (+2.36%)
Last: 11/14/2025, 7:00:00 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to ABNX.PA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 10.97. This target is 165.82% above the current price.
ABNX.PA was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ABNX.PA.
In the previous month the buy percentage consensus was at a similar level.
ABNX.PA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

ABNX.PA Historical Analyst RatingsABNX.PA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -107 -97 -87 -77 -67 -57 -47 -37 -27 -17 -7 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 4.1310.1010.9710.9712.08 - 144.85% 165.82% 165.82% 192.73%

Related screens

ABNX.PA Current Analyst RatingABNX.PA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

ABIONYX PHARMA SA / ABNX.PA FAQ

What is the average price target for ABIONYX PHARMA SA (ABNX.PA) stock?

8 analysts have analysed ABNX.PA and the average price target is 10.97 EUR. This implies a price increase of 165.82% is expected in the next year compared to the current price of 4.125.


How do analysts rate ABIONYX PHARMA SA (ABNX.PA)?

The consensus rating for ABIONYX PHARMA SA (ABNX.PA) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.